{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:32:12Z","timestamp":1786717932368,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Family Med Prim Care"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jfmpc.jfmpc_93_19","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T02:06:41Z","timestamp":1559527601000},"page":"1741","source":"Crossref","is-referenced-by-count":9,"title":["Using caffeine on the patients as therapeutic option against treatment-resistant obsessive-compulsive disorder"],"prefix":"10.4103","volume":"8","author":[{"given":"ElaheSamadi","family":"Soufi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Zahiroddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shekarriz-Foumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2249-4863.259455-1","first-page":"pii: 17m11552","volume-title":"Treatment-refractory obsessive-compulsive disorder in adults: A cost-effectiveness analysis of treatment strategies","author":"Gregory","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/2249-4863.259455-2","first-page":"bav069","volume-title":"OCDB: A database collecting genes, miRNAs and drugs for obsessive-compulsive disorder","author":"Privitera","year":"2015","journal-title":"Database (Oxford)"},{"key":"key-10.4103\/2249-4863.259455-3","first-page":"g2183","volume-title":"Obsessive-compulsive disorder","author":"Veale","year":"2014","journal-title":"BMJ"},{"key":"key-10.4103\/2249-4863.259455-4","first-page":"375","volume-title":"Pharmacological treatment of obsessive-compulsive disorder","author":"Pittenger","year":"2014","journal-title":"Psychiatr Clin North Am"},{"key":"key-10.4103\/2249-4863.259455-5","first-page":"403","volume-title":"Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology","author":"Baldwin","year":"2014","journal-title":"J Psychopharmacol"},{"key":"key-10.4103\/2249-4863.259455-6","first-page":"e13","volume-title":"Obsessive-compulsive disorder in youth: Assessment and treatment","author":"Wells","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/2249-4863.259455-7","first-page":"1530","volume-title":"Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder","author":"Koran","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/2249-4863.259455-8","first-page":"81","volume-title":"Neurobehavioral hazard identification and characterization for caffeine","author":"Turnbull","year":"2016","journal-title":"Regul Toxicol Pharmacol"},{"key":"key-10.4103\/2249-4863.259455-9","first-page":"1","volume-title":"Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review","author":"Rivera-Oliver","year":"2014","journal-title":"Life Sci"},{"key":"key-10.4103\/2249-4863.259455-10","first-page":"208","volume-title":"Caffeine potentiates the release of GABA mediated by NMDA receptor activation: Involvement of A1 adenosine receptors","author":"Ferreira","year":"2014","journal-title":"Neuroscience"},{"key":"key-10.4103\/2249-4863.259455-11","first-page":"59","volume-title":"The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine","author":"Powell","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"key-10.4103\/2249-4863.259455-12","first-page":"83","volume-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","author":"Fredholm","year":"1999","journal-title":"J Pharmacol Rev"},{"key":"key-10.4103\/2249-4863.259455-13","first-page":"S239","volume-title":"Caffeine, mental health, and psychiatric disorders","author":"Lara","year":"2010","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:29:24Z","timestamp":1786714164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_93_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["259455"],"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_93_19","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}